Bicara Therapeutics' CMO Sells 5,500 Shares for $126,000
Bicara Therapeutics' Chief Medical Officer, David Raben, sold 5,500 shares of the company's stock for $126,000 on April 27, 2026. The transaction represented 9.05% of his direct holdings at the time and was executed via an option exercise followed by an immediate sale. The sale did not involve any indirect entities.
Tickers: $BCAX
Topics: executive sales insider trading SEC filings stock transactions